2, 22 Other dermatological manifestations that present in association with LE and are included in Gilliams classification are non-scarring hair loss, urticaria, lichen planus, erythema multiforme, papulonodular mucinosis, calcinosis cutis, rheumatoid nodules, cutis laxa, anetoderma, acanthosis nigricans, sclerodactyly, LE- non-specific bullous lesions and leg ulcers (Table 1)
In contrast, weight loss magnitude during the pre-landmark period was not significantly associated with post-landmark all-cause mortality ( P = 0.14), the composite cardiovascular endpoint ( P = 0.55), incident cerebrovascular disease ( P = 0.25), incident heart failure ( P = 0.89), or incident valvular or rheumatic heart disease ( P = 0.43) (Fig
(2025, October 28)
Semaglutide is a GLP-1 receptor agonist, while tirzepatide is a dual GLP-1/GIP receptor agonist